✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Levolet is a drug marketed by Genus Lifesciences and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in LEVOLET is levothyroxine sodium. There are ten drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
A generic version of LEVOLET was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Recent Clinical Trials for LEVOLET
Identify potential brand extensions & 505(b)(2) entrants
|Dr. Reddy's Laboratories Limited||Phase 4|
|Dr. Reddy's Laboratories Limited|
LEVOLET is protected by two US patents.